FCG Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-179,710
| Closed | -$17.8M | – | 173 |
|
|
2019
Q3 | $17.8M | Sell |
179,710
-375
| -0.2% | -$35.6K | 5.44% | 5 |
|
|
2019
Q2 | $16.6M | Sell |
180,085
-2,217
| -1% | -$211K | 5.25% | 5 |
|
|
2019
Q1 | $17.2M | Sell |
182,302
-5,585
| -3% | -$488K | 5.69% | 5 |
|
|
2018
Q4 | $12M | Sell |
187,887
-1,454
| -0.8% | -$107K | 4.59% | 5 |
|
|
2018
Q3 | $16.9M | Sell |
189,341
-196
| -0.1% | -$17.3K | 5.82% | 5 |
|
|
2018
Q2 | $15.1M | Sell |
189,537
-153,781
| -45% | -$12.8M | 5.45% | 5 |
|
|
2018
Q1 | $30.6M | Buy |
343,318
+136,962
| +66% | +$13.1M | 10.58% | 2 |
|
|
2017
Q4 | $21.5M | Sell |
206,356
-2,113
| -1% | -$238K | 8% | 3 |
|
|
2017
Q3 | $30.4M | Sell |
208,469
-143,625
| -41% | -$19.6M | 11.24% | 2 |
|
|
2017
Q2 | $45.7M | Buy |
352,094
+138,799
| +65% | +$17M | 15.31% | 2 |
|
|
2017
Q1 | $26.5M | Sell |
213,295
-5,704
| -3% | -$683K | 10.71% | 2 |
|
|
2016
Q4 | $25.3M | Sell |
218,999
-142,388
| -39% | -$15.9M | 11.37% | 2 |
|
|
2016
Q3 | $37.8M | Buy |
361,387
+137,039
| +61% | +$14.8M | 11.6% | 2 |
|
|
2016
Q2 | $22.1M | Sell |
224,348
-140,157
| -38% | -$14.5M | 6.92% | 4 |
|
|
2016
Q1 | $36.5M | Sell |
364,505
-1,243
| -0.3% | -$128K | 12.79% | 2 |
|
|
2015
Q4 | $43.8M | Sell |
365,748
-1,034
| -0.3% | -$120K | 26.29% | 1 |
|
|
2015
Q3 | $24.5M | Buy |
366,782
+136,864
| +60% | +$17M | 20.25% | 1 |
|
|
2015
Q2 | $26.6M | Sell |
229,918
-286,900
| -56% | -$32.8M | 20.91% | 1 |
|
|
2015
Q1 | $59.6M | Sell |
516,818
-9,442
| -2% | -$1.13M | 30.57% | 1 |
|
|
2014
Q4 | $59.7M | Buy |
526,260
+95,009
| +22% | +$10M | 29.47% | 1 |
|
|
2014
Q3 | $49M | Buy |
431,251
+105,939
| +33% | +$9.56M | 32.26% | 1 |
|
|
2014
Q2 | $30.2M | Sell |
325,312
-198,020
| -38% | -$15.1M | 22.88% | 1 |
|
|
2014
Q1 | $36.5M | Sell |
523,332
-11,514
| -2% | -$912K | 25.92% | 1 |
|
|
2013
Q4 | $45.2M | Sell |
534,846
-640
| -0.1% | -$50.6K | 30.47% | 1 |
|
|
2013
Q3 | $41.3M | Sell |
535,486
-14,292
| -3% | -$1M | 29.38% | 1 |
|
|
2013
Q2 | $32.2M | Buy |
+549,778
| New | +$33.1M | 26.09% | 1 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
FCG Advisors's CELG Position: Q4 2019 in Review
FCG Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 179,710 shares — an estimated $17.8M sold.
FCG Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $59.7M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- FCG Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- FCG Advisors sold 179,710 Celgene Corp shares in Q4 2019, an estimated $17.8M.
- FCG Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- FCG Advisors's Celgene Corp position peaked at $59.7M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on FCG Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.